Etubics Competitors and Similar CompaniesClear all
Etubics's competitors and similar companies include Chemotargets, Spring Bank Pharmaceuticals, Histogen and Cerapedics.
 Etubics Etubics is a biopharmaceutical company developing targeted immunotherapies and vaccine products for a range of resilient diseases |  Chemotargets Chemotargets is a biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals. |  Spring Bank Pharmaceuticals Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. |  Histogen Histogen is a company developing a biological platform that replaces and regenerates tissues in the body. |  Cerapedics Cerapedics is an orthobiologics company developing the synthetic small peptide (P-15) technology platform. | |
Founding Date | Founding Date 2005 | Founding Date 2006 | Founding Date 2002 | Founding Date 2007 | Founding Date 2001 |
Type | Type Subsidiary | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Seattle, US HQ Louisville, US | Locations Barcelona, ES HQ | Locations Hopkinton, US HQ Hopkinton, US Milford, US | Locations San Diego, US HQ | Locations Westminster, US HQ |
Employees | Employees 7 | Employees 30 | Employees 303% increase | Employees 15 | Employees 1982% decrease |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 6m (over 9 years ago) | Latest funding round $ 22m (almost 8 years ago) |
Total funding raised | Total funding raised $ 4.4m | Total funding raised N/A | Total funding raised $ 14.4m | Total funding raised $ 46.3m | Total funding raised $ 69.6m |
For sources of this data, please see the company profile
View Company Profiles
Chemotargets
HQ
Barcelona, ES
Employees
30
Chemotargets is a biotech company focused on the discovery and development areas of small molecule pharmaceuticals and cosmeceuticals.
View companySpring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
30↑ 3% increase
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
View companyHistogen
HQ
San Diego, US
Employees
15
Histogen is a company developing a biological platform that replaces and regenerates tissues in the body.
View companyCerapedics
HQ
Westminster, US
Employees
198↓ 2% decrease
Cerapedics is an orthobiologics company developing the synthetic small peptide (P-15) technology platform.
View company